climate change

R&D

Scope for action: How the life sciences industry can make pr...

With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.

News

Public wants pharma to reveal carbon footprint of drugs

A survey has found that there is strong consumer support for pharma manufacturers to disclose the carbon footprint of their medicines, amid rising public scrutiny of the e

News

AstraZeneca pledges $400m to fight deforestation

AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib

Patients

Climate crisis: the greatest health threat of our time

Across all sectors and throughout the world, organisations are striving to achieve the United Nations Sustainable Development Goals. However, to achieve these, we need to think holistically.

Events

Anthropy 2022 - Day Two

Thursday 3rd November marks the second day of Anthropy 2022 at the Eden Project on the Cornish coast.

Views & Analysis

Pharma’s climate change vulnerability and opportunity

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.